Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_provenance.
- NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_assertion description "[In addition, geldanamycin (HSP90 inhibitor) and two CHK1 inhibitors (UCN-01 and SB218078) exhibited a significantly stronger synergism with cisplatin in FA-proficient cells when compared to FA-deficient cells, suggesting a contribution of their FA pathway inhibitory activity to cisplatin sensitization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_provenance.
- NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_assertion evidence source_evidence_literature NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_provenance.
- NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_assertion SIO_000772 22537224 NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_provenance.
- NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_assertion wasDerivedFrom befree-20140225 NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_provenance.
- NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_assertion wasGeneratedBy ECO_0000203 NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP262257.RAQOKwFs5pS4hz9EYFWTB3VMys6ok6ruzBKlBHNXxZjc4130_provenance.